The global compound management market is projected to reach USD 424.5 million in 2023 from USD 188.0 million in 2017, at CAGR of 14.5%. The base year considered for the study is 2017, and the forecast for the market size is provided for the period between 2018 and 2023. In the current market scenario, the growth of the market can be attributed to the increasing drug discovery activities, growing biopharmaceutical industry, and rising trend in outsourcing compound/sample management. On the other hand, the large capital investments needed to establish compound management facilities is the major factor restraining market growth.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=182172928 
According to a new market research report "Compound Management Market by Product & Outsourcing Services (Instruments (Automated Storage, Decapper), Software), Sample (Chemical Compounds, Biological Samples), End User (Biopharma Companies, Biobank, Pharma Companies, CRO) - Global Forecast to 2023", published by MarketsandMarkets™, the global market is projected to reach USD 424.5 million in 2023 from USD 215.3 million in 2018, at CAGR of 14.5%.Browse 95 market data Tables and 24 Figures spread through 118 Pages and in-depth TOC on "Compound Management Market"
Increasing drug discovery activity :Rising R&D expenditure globally has driven the pace of drug discovery. Most major players in the pharmaceutical industry have committed substantial investments to R&D to fulfill the demand for more effective drugs and therapies, which has proven beneficial to the compound/sample management market.Additionally, the demand for automated compound/sample management is expected to gain momentum in the coming years due to the growing government funding for biotech and drug discovery research worldwide.
Request Sample Report :- https://www.marketsandmarkets.com/requestsampleNew.asp?id=182172928
North America is expected to account for the largest share of the market in 2018Among the four geographic regions, North America is expected to account for the largest share of the Compound Management Market in 2018, followed by Europe, APAC, and the RoW. The large share of North America is attributed to the presence of the large pharmaceutical and biopharma industry. As a result, several companies in North America are engaged in drug discovery activities, which require maintenance of huge chemical libraries. Moreover, to maintain productivity of such innovative drugs and biologics, most of the leading pharma and biopharma companies have started building compound management facilities.
Market PlayersThe Compound Management Market is highly competitive due to the presence of a large number of players. Few companies that provide compound management systems are Brooks Life Sciences (US), Hamilton Company (US), TTP Group (UK), Labcyte (US), Biosero (US), and Tecan (Switzerland).
The global compound management market is projected to reach USD 424.5 million in 2023 from USD 188.0 million in 2017, at CAGR of 14.5%. The base year considered for the study is 2017, and the forecast for the market size is provided for the period between 2018 and 2023. In the current market scenario, the growth of the market can be attributed to the increasing drug discovery activities, growing biopharmaceutical industry, and rising trend in outsourcing compound/sample management. On the other hand, the large capital investments needed to establish compound management facilities is the major factor restraining market growth.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=182172928
According to a new market research report "Compound Management Market by Product & Outsourcing Services (Instruments (Automated Storage, Decapper), Software), Sample (Chemical Compounds, Biological Samples), End User (Biopharma Companies, Biobank, Pharma Companies, CRO) - Global Forecast to 2023", published by MarketsandMarkets™, the global market is projected to reach USD 424.5 million in 2023 from USD 215.3 million in 2018, at CAGR of 14.5%.Browse 95 market data Tables and 24 Figures spread through 118 Pages and in-depth TOC on "Compound Management Market"Increasing drug discovery activity :Rising R&D expenditure globally has driven the pace of drug discovery. Most major players in the pharmaceutical industry have committed substantial investments to R&D to fulfill the demand for more effective drugs and therapies, which has proven beneficial to the compound/sample management market.Additionally, the demand for automated compound/sample management is expected to gain momentum in the coming years due to the growing government funding for biotech and drug discovery research worldwide.Request Sample Report :- https://www.marketsandmarkets.com/requestsampleNew.asp?id=182172928North America is expected to account for the largest share of the market in 2018Among the four geographic regions, North America is expected to account for the largest share of the Compound Management Market in 2018, followed by Europe, APAC, and the RoW. The large share of North America is attributed to the presence of the large pharmaceutical and biopharma industry. As a result, several companies in North America are engaged in drug discovery activities, which require maintenance of huge chemical libraries. Moreover, to maintain productivity of such innovative drugs and biologics, most of the leading pharma and biopharma companies have started building compound management facilities.Market PlayersThe Compound Management Market is highly competitive due to the presence of a large number of players. Few companies that provide compound management systems are Brooks Life Sciences (US), Hamilton Company (US), TTP Group (UK), Labcyte (US), Biosero (US), and Tecan (Switzerland).
The global market for tensiometer is primarily driven by the need to improve product quality and manufacturing processes, increasing pharmaceutical and biopharmaceutical R&D expenditure, and technological advancements. However, the reluctance to switch from conventional methods and a dearth of skilled personnel will challenge market growth.According to the new market research report “Tensiometer Market by Product (Optical, Force, Volumetric, Bubble Pressure Tensiometer, Accessories), Industry (Chemical, Oil & Gas, Energy, Pharmaceutical, Medical Devices, Cosmetics, Research Laboratory), Region - Global Forecast to 2024", published by MarketsandMarkets™ expected to reach USD 151 million by 2024 from an estimated value of USD 103 million in 2019, growing at a CAGR of 7.9% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=10015314
Global Tensiometer Market Segmentation:1. On the basis of product, the tensiometer market is segmented into optical tensiometers, force tensiometers, volumetric tensiometers, bubble pressure tensiometers, and accessories. The optical tensiometers segment accounted for the largest market share in 2018.2. On the basis of industry, the tensiometer market is segmented into chemical, oil & gas, energy, pharmaceutical & biopharmaceutical, medical device, cosmetic, and other industries (food & beverage, materials & composite, textile, and paper & packaging industries).Asia Pacific accounted for the largest share of the tensiometer market in 2018The market is segmented into five major regions, namely, North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa. In 2018, Asia Pacific accounted for the largest share of the tensiometer market. The factors such as chemical production growth in China, growth in Indian oil & gas industry, increasing demand for primary energy in India, and growth in medical device & pharmaceutical market in Asia are driving the growth of the tensiometer industry in this region.
Get Expert Analysis and Insights of Global Market | Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=10015314
Key Market Players :The key players in the global tensiometer market are KRÜSS GmbH (Germany), DataPhysics Instruments GmbH (Germany), Biolin Scientific AB (Sweden), Kyowa Interface Science Co. Ltd. (Japan), LAUDA Scientific GmbH (Germany), TECLIS Scientific (France), Apex Instruments Co. Pvt. Ltd. (India), Pro-Pack Materials (Singapore), USA KINO Industry Co. Ltd. (US), and Kibron Inc. Oy (Finland).
The report "Wireless Health Market by Technology (WPAN, WLAN/Wifi, WiMAX), by Component (Hardware, Software, & Services), by Application (Patient Specific and Provider/Payer Specific), & by End Users (Providers, & Payers) - Analysis & Global Forecast to 2020", This report studies the global wireless health market for the forecast period of 2015 to 2020. This market is expected to reach USD 110.12 Billion by 2020 from USD 39.03 Billion in 2015, at a CAGR of 23.1%.
The global wireless health market is projected to reach USD 110.12 Billion by 2020 from USD 39.03 Billion in 2015, at a CAGR of 23.1% during the forecast period of 2015 to 2020.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=551
Wireless health market segmentation:
• Basis of components
• Basis of technology
• Basis of applications
• Basis of end users
• Basis of region
Browse 139 tables and 37 figures spread through 214 Pages and in-depth TOC on "Wireless Health Market by Technology (WPAN, WLAN/Wifi, WiMax), by Component (Hardware, Software, & Services), by Application (Patient Specific and Provider/Payer Specific), & by End Users (Providers, & Payers) - Analysis & Global Forecast to 2020"
https://www.marketsandmarkets.com/Market-Reports/wireless-healthcare-market-551.html
Early buyers will receive 10% customization on reports.
The global wireless health market is segmented on the basis of technologies, components, applications, end users, and regions.
On the basis of components, the wireless health market is segmented into hardware, software, and services. The software segment is expected to grow rapidly during the forecast period. The increasing need of advancements in healthcare software and rising adoption of healthcare IT solutions are the major driving factors for growth of this market.
Read More in Detailed (Wireless health market):
https://www.marketsandmarkets.com/PressReleases/wireless-health.asp
According to the new market research report “Varicose Vein Treatment Market in North America and Europe by Treatment Mode (Endovenous Ablation, Sclerotherapy, Stripping), Products (Laser & RF Ablation, Venous Closure, Surgical) - Forecasts to 2021", published by MarketsandMarkets™, The varicose vein treatment market in North America and Europe is expected to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, at a CAGR of 6.9% between 2016 and 2021.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=22524107
The global market in North America and Europe is expected to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, at a CAGR of 6.9% between 2016 and 2021. Shift towards less-invasive treatment procedures, availability of advanced varicose vein treatment devices, and huge burden of varicose vein cases in North America and Europe is driving the growth of the market. Other growth factors include improving patient compliance & reliability, growing healthcare expenditure, and rapid growth in aging population.
Major key players :Major players in the varicose vein treatment market include Medtronic plc (Ireland); AngioDynamics, Inc. (U.S.); biolitec AG (Austria); Syneron Medical Ltd. (Israel); Lumenis Ltd. (Israel); Dornier MedTech GmbH (Germany); Energist Group (U.K.); Eufoton s.r.l. (Italy); Vascular Solutions, Inc. (U.S.); Quanta System S.p.A. (Italy); Sciton, Inc. (U.S.); Fotona d.o.o. (Slovenia); BTG plc (U.K.); and Merz Aesthetics (U.S.), among othersVaricose Vein Treatment Market segmented into :+ On the basis of mode of treatment, the market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping. The endovenous ablation segment is expected to command the major share of the market, by mode of treatment, in 2016.+ Based on type of products, the market is segmented into ablation devices, venous closure products, and surgical products. The ablation devices segment is further categorized into radiofrequency ablation devices and laser ablation devices.+ This report covers the market across two major geographies, namely, North America and Europe. In this report, the North American market is further segmented into the U.S. and Canada, while the European market is categorized into Germany, U.K., France, Italy, Spain, and Rest of Europe. In 2016, North America is expected to command the largest share of the market in North America and Europe.Get Sample Copy of This Report@https://www.marketsandmarkets.com/requestsampleNew.asp?id=22524107
The global vaccine adjuvants market is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016, at a CAGR of 10.5%. The global market is broadly classified into product type, route of administration, disease type, applications, and application categories.The global market is broadly classified into product type, route of administration, disease type, applications, and application categories.On the basis of product type, the market is segmented into pathogen components, adjuvant emulsions, particulate adjuvants, combination adjuvants, and other adjuvants.Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=152603894
What Drives the Market?1. Increasing Use of Adjuvants in Vaccine2. High Prevalence of Infectious and Zoonotic Diseases3. Increase in Livestock and Instances of Diseases4. Increasing Focus on Immunization Programs From Various Government Bodies5. Technological Advancements in Aluminum Hydroxide-Based Adjuvants6. Increasing Focus and Support on the Discovery and Development of Vaccine Adjuvants7. Increasing Geriatric PopulationGlobal Vaccine Adjuvants Market Segmentation:The global market is broadly classified into product type, route of administration, disease type, applications, and application categories.+ On the basis of product type, the vaccine adjuvants market is segmented into pathogen components, adjuvant emulsions, particulate adjuvants, combination adjuvants, and others. The particulate adjuvants segment is expected to account for the largest share of the global market in 2016. The adjuvant emulsions segment, on the other hand, is projected to grow at the highest CAGR during the forecast period.+ On the basis of route of administration, the market is segmented into oral, subcutaneous, intranasal, intramuscular, intradermal, and others. The intramuscular segment is expected to account for the largest share of the global vaccine adjuvants market in 2016.+ On the basis of disease type, the vaccine adjuvants market is segmented into infectious diseases, cancer, and others. The infectious diseases segment is expected to account for the largest share of the global market in 2016. Factors such as high prevalence of infectious diseases, government & company initiatives, and high prevalence of cancer cases are expected to drive market growth in the coming years.
Get Expert Analysis and Insights of Global Market | Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=152603894Geographical Growth Analysis:Geographically, the vaccine adjuvants market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). However, Asia is projected to grow at the highest CAGR during the forecast period. Growth in the North American segment is primarily driven by the increasing geriatric population and rising incidences of diseases in the North American countries.
According to the new market research report " anatomic pathology market by Product & Service (Instruments (Tissue Processing Systems, Microtome), Consumables (Reagent & Antibodies), Histopathology, Cytopathology), Application (Disease Diagnosis, Drug Discovery & Development) - Forecasts to 2021", published by MarketsandMarkets™, The anatomic pathology market was valued at USD 16.2 Billion in 2016 and poised to grow at a CAGR of 6.1% between 2016 and 2021, to reach USD 21.9 Billion in 2021.
Download PDF Brochure :https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145
The high incidence of cancer and other target diseases, availability of reimbursement, and the growing focus on personalized medicine are the major factors driving the growth of the anatomic pathology market.Market segmented into :1. By product & service, the market is segmented into services, instruments, and consumables. The services segment accounted for the largest market share in 2018 and is expected to register the highest CAGR during the forecast period. The growth of this segment can be attributed to the availability of reimbursements for diagnostic tests, rapid growth in the geriatric population, and the increasing incidence of cancer and other chronic diseases.2. Based on application, the market is segmented into disease diagnosis and medical research. The market for disease diagnosis is further segmented into cancer and other diseases. In 2018, the disease diagnosis segment accounted for the largest market share. This can be attributed to the rapid growth in the geriatric population and the increasing incidence of cancer and other chronic diseases.3. Based on region, the market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2018, North America accounted for the largest market share, followed by Europe. The easy accessibility to advanced technologies, government initiatives for screening cancer patients, favorable reimbursement scenario for anatomic pathology diagnostic tests, increasing healthcare expenditure, and the presence of high-quality infrastructure for hospitals and clinical laboratories in the region are the major factors driving the growth of the market in North America.
Get Expert Analysis and Insights of Global Market | Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=137323145Some of The Major Players In Anatomic Pathology Market:Prominent players in the anatomic pathology market include F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Thermo Fisher Scientific (US), Hologic, Inc. (US), Agilent Technologies (US), Becton, Dickinson and Company (US), Sakura Finetek (Japan), Merck KGaA (Germany), Bio SB (US), Diapath S.p.A. (Italy), and BioGenex Laboratories (US).Geographical Growth Analysis:Based on region, the market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2018, North America accounted for the largest market share, followed by Europe. The easy accessibility to advanced technologies, government initiatives for screening cancer patients, favorable reimbursement scenario for anatomic pathology diagnostic tests, increasing healthcare expenditure, and the presence of high-quality infrastructure for hospitals and clinical laboratories in the region are the major factors driving the growth of the market in North America.
The global compound management market is projected to reach USD 424.5 million in 2023 from USD 188.0 million in 2017, at CAGR of 14.5%. The base year considered for the study is 2017, and the forecast for the market size is provided for the period between 2018 and 2023. In the current market scenario, the growth of the market can be attributed to the increasing drug discovery activities, growing biopharmaceutical industry, and rising trend in outsourcing compound/sample management. On the other hand, the large capital investments needed to establish compound management facilities is the major factor restraining market growth.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=182172928
According to a new market research report "Compound Management Market by Product & Outsourcing Services (Instruments (Automated Storage, Decapper), Software), Sample (Chemical Compounds, Biological Samples), End User (Biopharma Companies, Biobank, Pharma Companies, CRO) - Global Forecast to 2023", published by MarketsandMarkets™, the global market is projected to reach USD 424.5 million in 2023 from USD 215.3 million in 2018, at CAGR of 14.5%.
Browse 95 market data Tables and 24 Figures spread through 118 Pages and in-depth TOC on "Compound Management Market"Increasing drug discovery activity :Rising R&D expenditure globally has driven the pace of drug discovery. Most major players in the pharmaceutical industry have committed substantial investments to R&D to fulfill the demand for more effective drugs and therapies, which has proven beneficial to the compound/sample management market.Additionally, the demand for automated compound/sample management is expected to gain momentum in the coming years due to the growing government funding for biotech and drug discovery research worldwide.Request Sample Report :- https://www.marketsandmarkets.com/requestsampleNew.asp?id=182172928North America is expected to account for the largest share of the market in 2018Among the four geographic regions, North America is expected to account for the largest share of the Compound Management Market in 2018, followed by Europe, APAC, and the RoW. The large share of North America is attributed to the presence of the large pharmaceutical and biopharma industry. As a result, several companies in North America are engaged in drug discovery activities, which require maintenance of huge chemical libraries. Moreover, to maintain productivity of such innovative drugs and biologics, most of the leading pharma and biopharma companies have started building compound management facilities.Market PlayersThe Compound Management Market is highly competitive due to the presence of a large number of players. Few companies that provide compound management systems are Brooks Life Sciences (US), Hamilton Company (US), TTP Group (UK), Labcyte (US), Biosero (US), and Tecan (Switzerland).
According to the new market research report “Autoinjectors Market by Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Cardiovascular diseases, Psoriasis, Migraine), Type (Disposable, and Reusable), End Users (Homecare, and Hospitals) - Global Forecast to 2023", published by MarketsandMarkets™, The global Autoinjectors Market is projected to reach USD 85.31 billion by 2023 from an estimated USD 28.91 billion in 2018, at a CAGR of 24.2% during the forecast period (2018-2023).
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173991724
The key factors driving the growth of this market include the growing prevalence of targeted therapies such as rheumatoid arthritis and multiple sclerosis, rising incidence of anaphylaxis, and increasing number of regulatory approvals.
Use of autoinjectors in the treatment of rheumatoid arthritis drives the global autoinjectors market
Rheumatoid arthritis (RA) is a chronic, systemic, inflammatory autoimmune disease that affects connective tissues. It causes joints to swell and can result in pain, stiffness, and progressive loss of function. According to the CDC, an estimated 43.7 million adults (22.7% of the total population) in the US annually are affected by some form of arthritis, RA, gout, lupus, or fibromyalgia.
Global Autoinjectors Market Segmentation:
+ On the basis of type, the market is segmented into disposable and reusable autoinjectors. The disposable autoinjectors segment is expected to account for the largest market share in 2017. This can primarily be attributed to their ease of use and the presence of a built-in glass syringe which makes it more convenient for patients with reduced dexterity or visual impairments.
+ On the basis of therapy, the market is segmented into rheumatoid arthritis, multiple sclerosis, anaphylaxis, diabetes, migraine, and other therapies (includes cardiovascular diseases, migraine treatment, anemia, and progesterone therapy). The rheumatoid arthritis segment accounted for the largest share of the market in 2017. The large share of this segment is mainly attributed to the high prevalence of rheumatoid arthritis across the globe.
+ On the basis of end users, the market is segmented into home care settings and hospitals & clinics. The home care settings segment commanded the largest share of the market in 2017. The large share of this end-user segment can primarily be attributed to the rapid growth in the geriatric population across the globe and the growing need for cost-effective drug administration.
Get Expert Analysis and Insights of Global Market | Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=173991724
What Drives the Market?
1. Growing prevalence of targeted therapies
2. Rising incidence of anaphylaxis
3. Increasing number of regulatory approvals
4. Availability of generic versions of autoinjectors
Geographical Growth Analysis:
In 2018, North America is expected to account for the largest share of the autoinjectors market, followed by Europe. Factors such as increasing geriatric population in Canada, increasing FDA approvals, rising prevalence of anaphylaxis in the US, and rising prevalence of autoimmune and chronic diseases in the US and Canada are contributing to the large share of North America.
Key Players and Strategies Adopted by Them:
The key players in the global autoinjectors market are Abbvie (US), Amgen (US), Teva (Israel), Biogen (US), Eli Lilly (US), and Mylan (US). The other prominent players in the market are J&J (US), Novartis (Switzerland), Bayer (Germany), Merck (Germany), Biogen (US), Ypsomed (Switzerland), SHL Group (Taiwan) Becton, Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), and Haselmeier (Switzerland).
The synthetic biology market comprises a network of players involved in the research and product development; raw material supply; component manufacturing; distribution and sale; and post-sales services. Key players considered in the analysis of the global market are Thermo Fisher (US), Novozymes (Denmark), Merck KGaA (Germany), Intrexon (US), and Agilent Technologies (US), Amyris (US), GenScript (US), Ginkgo Bioworks (US), Integrated DNA Technologies (US), New England Biolabs (US), Synthetic Genomics (US), and Twist Bioscience (US).The global synthetic biology market is expected to grow from USD 3.57 billion in 2017 to USD 8.84 billion by 2022, at a CAGR of 19.9% from 2017 to 2022.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=889
Synthetic biology has an array of applications in the fields of medicine, agriculture, nanotechnology, and industrial biotechnology. This has attracted interests of researchers from across the globe and has led to a rise in funding from public and private organizations, which, in turn, help in the growth of the market.Additionally, the reduction in costs per raw megabase of DNA sequencing and a drastic reduction in the cost of synthetic genes is expected to propel the market growth of synthetic biology. The base year considered for the study is 2016, and the forecast has been provided for the period between 2017 and 2022.Global Synthetic Biology Market Segmentation:In this report, the market is segmented by tool, technology, application, and region. On the basis tool, the synthetic biology market is segmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms, and xeno-nucleic acids. The chassis organisms segment is expected to grow at the highest rate during the forecast period. The increasing demand for green alternatives (biomass is converted to chemicals using engineered bacteria, yeasts, and other microorganisms) to fossil fuels is a key driver for this segment.By technology, the market is segmented into gene synthesis, genome engineering, cloning and sequencing, next-generation sequencing, site-directed mutagenesis, measurement and modeling, microfluidics, and nanotechnology. In 2017, the gene synthesis segment is expected to account for the largest share of the market in technology.The market is segmented into medical (pharmaceutical, drug discovery & therapeutics, and artificial tissue and tissue regeneration), industrial (biofuel & renewable energy, industrial enzymes, and biomaterials & green chemicals), food & agriculture, and environmental (bioremediation and biosensing) on the basis of application.Get Expert Analysis and Insights of Global Market | Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=889Wide range of applications of synthetic biology drives the global synthetic biology marketThe field of medicine has been in the forefront in terms of developing and applying synthetic biology techniques for various applications. Advancements in DNA sequencing and synthesizing technologies have resulted in the better understanding of diseases, aiding the research and discovery of biopharmaceuticals, small molecules, regenerative medicine, and antibody research.Additionally, synthetic biology has major applications in developing disease-resistant, drought-tolerant, and high-yielding crop. Similarly, industrial applications of synthetic biology are expected to replace petrochemicals with bio-based chemicals in the near future. The growing applications of synthetic biology is a major driver for the growth of this market.
The report "Wireless Health Market by Technology (WPAN, WLAN/Wifi, WiMAX), by Component (Hardware, Software, & Services), by Application (Patient Specific and Provider/Payer Specific), & by End Users (Providers, & Payers) - Analysis & Global Forecast to 2020", This report studies the global wireless health market for the forecast period of 2015 to 2020. This market is expected to reach USD 110.12 Billion by 2020 from USD 39.03 Billion in 2015, at a CAGR of 23.1%.The global wireless health market is projected to reach USD 110.12 Billion by 2020 from USD 39.03 Billion in 2015, at a CAGR of 23.1% during the forecast period of 2015 to 2020.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=551
Browse 139 tables and 37 figures spread through 214 Pages and in-depth TOC on "Wireless Health Market by Technology (WPAN, WLAN/Wifi, WiMax), by Component (Hardware, Software, & Services), by Application (Patient Specific and Provider/Payer Specific), & by End Users (Providers, & Payers) - Analysis & Global Forecast to 2020"Growth in the overall market can largely be attributed to factors such as increasing advancements in wireless communication technologies, growing internet penetration, increasing utilization of connected devices in the management of chronic diseases, rising adoption of a patient-centric approach by healthcare providers, robust penetration of 3G and 4G networks in healthcare services, and mainstreaming of cloud computing.The market is expected to witness the highest growth in the Asia-Pacific region in the coming years. Growth in the Asia-Pacific region can be attributed to factors such as increasing population, growing internet penetration, rising medical tourism, increasing government initiatives for eHealth, and growing demand for quality healthcare.Request Sample Report :- https://www.marketsandmarkets.com/requestsampleNew.asp?id=551On the basis of technology, the wireless health market is further segmented into WPAN, WLAN/WiFi, WiMAX and WWAN. The WPAN technology market segment accounts for the largest share of the global wireless health market in 2015. WPAN links wireless health devices with computers, increasing accessibility to care. The WPAN technology segment is further segmented into Bluetooth, RFID, Ant+, Zigbee, Z-wave, and UWB. The Bluetooth segment accounts for the largest share of the WPAN market in 2015. Low costs and highly secure facilities are factors that have increased the share of WPAN technologies in the wireless health market.Federal mandates such as Meaningful Use Stage II and growing adoption of wireless health devices among the elderly and patients suffering from chronic illnesses are some of the factors driving the growth of the wireless health market.Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=551
The global compound management market is projected to reach USD 424.5 million in 2023 from USD 188.0 million in 2017, at CAGR of 14.5%. The base year considered for the study is 2017, and the forecast for the market size is provided for the period between 2018 and 2023. In the current market scenario, the growth of the market can be attributed to the increasing drug discovery activities, growing biopharmaceutical industry, and rising trend in outsourcing compound/sample management. On the other hand, the large capital investments needed to establish compound management facilities is the major factor restraining market growth.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=182172928
According to a new market research report “Compound Management Market by Product & Outsourcing Services (Instruments (Automated Storage, Decapper), Software), Sample (Chemical Compounds, Biological Samples), End User (Biopharma Companies, Biobank, Pharma Companies, CRO) – Global Forecast to 2023”, published by MarketsandMarkets™, the global market is projected to reach USD 424.5 million in 2023 from USD 215.3 million in 2018, at CAGR of 14.5%.Browse 95 market data Tables and 24 Figures spread through 118 Pages and in-depth TOC on “Compound Management Market”Increasing drug discovery activity :Rising R&D expenditure globally has driven the pace of drug discovery. Most major players in the pharmaceutical industry have committed substantial investments to R&D to fulfill the demand for more effective drugs and therapies, which has proven beneficial to the compound/sample management market.Additionally, the demand for automated compound/sample management is expected to gain momentum in the coming years due to the growing government funding for biotech and drug discovery research worldwide.Request Sample Report :- https://www.marketsandmarkets.com/requestsampleNew.asp?id=182172928North America is expected to account for the largest share of the market in 2018Among the four geographic regions, North America is expected to account for the largest share of the Compound Management Market in 2018, followed by Europe, APAC, and the RoW. The large share of North America is attributed to the presence of the large pharmaceutical and biopharma industry. As a result, several companies in North America are engaged in drug discovery activities, which require maintenance of huge chemical libraries. Moreover, to maintain productivity of such innovative drugs and biologics, most of the leading pharma and biopharma companies have started building compound management facilities.Market PlayersThe Compound Management Market is highly competitive due to the presence of a large number of players. Few companies that provide compound management systems are Brooks Life Sciences (US), Hamilton Company (US), TTP Group (UK), Labcyte (US), Biosero (US), and Tecan (Switzerland).
